This is a beta version of the new GtoPdb home page - take the tour and let us know what you think.

Recent Twitter activity

Sorry, this content is unavailable until you click to accept cookies from this site.
ACCEPT COOKIES

Advanced Search: Targets | Target Pharmacology | Ligands | Chemical Structure

Creative Commons Licence Current Release Version 2020.3 (19th Jun 2020). Read our release notes blog.

Coronavirus (Covid-19) - view our information page

GtoImmuPdb

GtoImmuPdb logo

Visit the IUPHAR Guide to IMMUNOPHARMACOLOGY portal
An immunological access-point to GtoPdb data

GtoMPdb

GtoMPdb logo

Visit the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY portal
Optimised access to GtoPdb data for the malaria research community

Ligand Activity Charts

GtoPdb Ligand Activity Charts

View interactive ligand activity charts that summarise pharmacological information and allows comparison across species

Latest News and Hot Topics in Pharmacology

powered by Surfing Waves

All news    Our blog    Hot topics    Latest pairings

The Concise Guide to PHARMACOLOGY 2019/20

Concise Guide to Pharmacology 2019/20

Access the table of contents

Please see the 5 minute introductory video on the Concise Guide:

Recent Publications

BJP journal cover

IUPHAR review article on two-pore domain potassium channels

Gada K & Plant LD (2019) Br J Pharmacol. 176(2):256-266. doi: 10.1111/bph.14518.

IUPHAR review article on the pharmacology of calcitonin/CGRP family of peptides

Hay DL, Garelja ML, Poyner DR, et al. (2018) Br J Pharmacol. 175(1):3-17. doi: 10.1111/bph.14075.

Pharm Rev journal cover

IUPHAR review article on Structure and Pharmacology of the Apelin Receptor

Read C, Nyimanu D, Williams TL, Huggins DJ, Sulentic P, Macrae RGC, Yang P, Glen RC, Maguire JJ and Davenport AP (2019) Pharmacol Rev. 71: 764-502.

IUPHAR review article on GABAA Receptor Subtype- and Function-selective Ligands

Sieghart W & Savić MM. (2018) Pharmacol Rev. 70: 836-878.

Celebrating >20 years of Servier support

Servier, a mid-size French Pharmaceutical company, has a long history in pharmacology, and has supported NC-IUPHAR for >20 years with unrestricted educational grants which have permitted the Paris meetings and thus progress of the database.